A clinical stage biotechnology company working on a rare genetic disorder is about to become a public company, and the deal behind it is worth...
Rare Disease
[stock_market_widget type=”card” template=”basic2″ assets=”IRD” realtime=”true” api=”yahoo-finance”] An early-stage gene-therapy program targeting a rare form of childhood blindness has quietly entered a new lane inside the...
[stock_market_widget type=”card” template=”basic2″ assets=”CPIX” realtime=”true” api=”yahoo-finance”] Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) builds its business around specialty pharmaceuticals. The company acquires, develops, and markets branded prescription...
